Bringing clinical trial visits directly to patients when and where it's convenient for them.

Accellacare In-Home Services can be provided in all phases and a wide range of therapeutic areas to:

  • Increase patient retention – patients are less likely to drop-out as their burden is reduced
  • Improve compliance – with more individual attention, support and oversight, patients are more likely to remain compliant with their trial regimen  
  • Accellerated patient enrolment – patients will consider participation because of the option to interact with study staff either at home or in more convenient locations   
  • Increased diversity – by reducing patient travel, In-Home Services expands a site's geographic reach allowing us access to new patient populations

Accellacare In-Home Services has successfully deployed these services for a range of clinical trials and has a comprehensive network in 60+ countries throughout the world.  

Realising the benefits of in-home services

Webinar: In-home visits to reduce patient burden

The FDA guidance on clinical trials during COVID-19 advised sponsors to evaluate alternative methods for safety assessments to protect patients, where necessary and feasible.

Watch the webinar recording

Solutions are tailored to specific study requirements, patient populations and include the following options:

  • Study drug administration (infusion, injection, topical, oral)
  • Collect blood samples (PK/PD, Safety Labs) and process with portable centrifuge
  • Collect urine and other biological samples
  • ECG test and device management
  • Patient training and education for self-administration
  • Body system assessments
  • Administer patient questionnaires, or check for completion
  • Check for changes in health, hospitalization, or concomitant medications
  • Record vital signs, height and weight
  • Complete visit documentation
  • Medical waste disposal
  • Source and manage ancillary supplies for in-home visits


Contact us  today to find out how reducing burden in clinical trials can improve predictability in clinical trials.